Aflac has shown resilience in 2025, with shares up more than 4% for the year, driven by defensive qualities and strong dividend growth history. Despite solid performance, Aflac appears overvalued with ...
Aflac (AFL) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good ...
Aflac Incorporated is rated a "Hold" due to overvaluation, despite strong fundamentals and historical performance. AFL's heavy Japan exposure presents FX and demographic risks, impacting future ...
A look at the shareholders of Aflac Incorporated (NYSE:AFL) can tell us which group is most powerful. We can see that ...
In the last year, many Aflac Incorporated ( NYSE:AFL ) insiders sold a substantial stake in the company which may ...
Aflac Incorporated (NYSE: AFL) announced today that it will release fourth quarter 2025 financial results after the market ...
Aflac Incorporated (NYSE:AFL) stands out as a major player in the supplemental insurance market in both the United States and Japan, offering policies related to life, cancer, and general health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback